Article
An Alternative Therapy for HCC with Portal Vein Tumor Thrombosis: Y-90 Radioembolization
Veysel Akgun,
Corresponding Author
Veysel Akgun
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
[email protected]Search for more papers by this author Bulent Karaman,
Bulent Karaman
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
Search for more papers by this author Sebahattin Sari,
Sebahattin Sari
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
Search for more papers by this author Mehmet Serindere,
Mehmet Serindere
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
Search for more papers by this author Salih Hamcan,
Salih Hamcan
Department of Radiology, Balıkesir Military Hospital, Balıkesir, Turkey
Search for more papers by this author
Veysel Akgun,
Corresponding Author
Veysel Akgun
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
[email protected]Search for more papers by this author Bulent Karaman,
Bulent Karaman
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
Search for more papers by this author Sebahattin Sari,
Sebahattin Sari
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
Search for more papers by this author Mehmet Serindere,
Mehmet Serindere
Department of Radiology, Gulhane Military Medical Academy, Ankara, Turkey
Search for more papers by this author Salih Hamcan,
Salih Hamcan
Department of Radiology, Balıkesir Military Hospital, Balıkesir, Turkey
Search for more papers by this author
First published: 08 October 2013
No abstract is available for this article.
References
- 1TangQH, LiAJ, YangGM, LaiEC, ZhouWP, JiangZH, LauWY, WuMC Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study. World J Surg (2013) 37(6): 1362–13702345622710.1007/s00268-013-1969-x
- 2LewandowskiRJ, SalemR Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Semin Interv Radiol (2006) 23(1): 64–7210.1055/s-2006-939842
